Published in Clin Infect Dis on September 01, 2005
Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev (2008) 17.77
Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect (2010) 1.94
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev (2015) 1.94
Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections. Antimicrob Agents Chemother (2007) 1.68
Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting. Intensive Care Med (2014) 1.64
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria. Antimicrob Agents Chemother (2007) 1.60
Vancomycin-associated nephrotoxicity: grave concern or death by character assassination? Am J Med (2010) 1.43
Antianaerobic antimicrobials: spectrum and susceptibility testing. Clin Microbiol Rev (2013) 1.37
In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2007) 1.33
Population pharmacokinetics of tigecycline in patients with complicated intra-abdominal or skin and skin structure infections. Antimicrob Agents Chemother (2006) 1.26
Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections. J Antimicrob Chemother (2014) 1.21
Effect of tigecycline on normal oropharyngeal and intestinal microflora. Antimicrob Agents Chemother (2006) 1.20
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin. Eur J Med Res (2010) 1.20
Newer antibacterial drugs for a new century. Expert Opin Investig Drugs (2010) 1.16
Destruction of spirochete Borrelia burgdorferi round-body propagules (RBs) by the antibiotic tigecycline. Proc Natl Acad Sci U S A (2009) 1.15
Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia. BMC Pulm Med (2009) 1.13
Validation and reproducibility assessment of tigecycline MIC determinations by Etest. J Clin Microbiol (2007) 1.09
Characterization and sequence analysis of extended-spectrum-{beta}-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials. Antimicrob Agents Chemother (2008) 1.08
Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. BMC Infect Dis (2010) 1.06
Pharmacodynamic profile of tigecycline against methicillin-resistant Staphylococcus aureus in an experimental pneumonia model. Antimicrob Agents Chemother (2009) 1.05
Influence of tigecycline on expression of virulence factors in biofilm-associated cells of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2009) 1.04
Multicenter evaluation of vancomycin dosing: emphasis on obesity. Am J Med (2008) 1.03
Tigecycline use in serious nosocomial infections: a drug use evaluation. BMC Infect Dis (2010) 1.02
Comparison of the efficacy and safety of oritavancin front-loaded dosing regimens to daily dosing: an analysis of the SIMPLIFI trial. Antimicrob Agents Chemother (2011) 1.00
Current and novel antibiotics against resistant Gram-positive bacteria. Infect Drug Resist (2008) 0.98
Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline. Antimicrob Agents Chemother (2007) 0.97
Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections. Ther Clin Risk Manag (2007) 0.95
Tigecycline (Tygacil): the first in the glycylcycline class of antibiotics. Proc (Bayl Univ Med Cent) (2006) 0.95
In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from a Belgian hospital. Eur J Clin Microbiol Infect Dis (2008) 0.90
Ceftaroline in complicated skin and skin-structure infections. Infect Drug Resist (2012) 0.86
Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections. Eur J Clin Microbiol Infect Dis (2013) 0.86
Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options. BMC Infect Dis (2015) 0.84
Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole. Ther Clin Risk Manag (2010) 0.83
Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients. PLoS One (2016) 0.82
Pharmacokinetics and safety of recently approved drugs used to treat methicillin-resistant Staphylococcus aureus infections in infants, children and adults. Expert Rev Clin Pharmacol (2014) 0.81
Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. BMC Pharmacol Toxicol (2013) 0.81
World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg (2014) 0.81
Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecycline. Infect Dis Rep (2012) 0.80
Postantibiotic effect of tigecycline against 14 gram-positive organisms. Antimicrob Agents Chemother (2008) 0.79
Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure. Antimicrob Agents Chemother (2015) 0.79
Treatment of Gram-positive infections in critically ill patients. BMC Infect Dis (2014) 0.78
Extended-spectrum beta-lactamase Klebsiella pneumoniae meningitis treated with tigecycline. Ann Saudi Med (2009) 0.78
Use of ribotyping to retrospectively identify methicillin-resistant Staphylococcus aureus isolates from phase 3 clinical trials for tigecycline that are genotypically related to community-associated isolates. Antimicrob Agents Chemother (2005) 0.78
Tigecycline versus levofloxacin in hospitalized patients with community-acquired pneumonia: an analysis of risk factors. Open Respir Med J (2013) 0.77
The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob (2017) 0.75
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections. BMC Infect Dis (2012) 0.75
Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria. Infection (2014) 0.75
Enterococcus faecium Mediastinitis Complicated by Disseminated Candida parapsilosis Infection after Congenital Heart Surgery in a 4-Week-Old Baby. Case Rep Infect Dis (2015) 0.75
Adjunctive Hyperbaric Oxygen Therapy or Alone Antibiotherapy? Methicillin Resistant Staphylococcus aureus Mediastinitis in a Rat Model. Rev Bras Cir Cardiovasc (2015) 0.75
In vitro activity of tigecycline against patient isolates collected during phase 3 clinical trials for hospital acquired pneumonia. Infect Dis Rep (2010) 0.75
Prescription Patterns for Tigecycline in Severely Ill Patients for Non-FDA Approved Indications in a Developing Country: A Compromised Outcome. Front Microbiol (2017) 0.75
Methicillin-Resistant Staphylococcus aureus: A Growing Risk in the Hospital and in the Community. Am Health Drug Benefits (2009) 0.75
Sick individuals and sick populations. Int J Epidemiol (1985) 23.44
Smoking and other risk factors for coronary heart-disease in British civil servants. Lancet (1976) 15.18
Inequalities in death--specific explanations of a general pattern? Lancet (1984) 13.99
Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) (1981) 11.00
Cardiorespiratory disease and diabetes among middle-aged male Civil Servants. A study of screening and intervention. Lancet (1974) 10.02
Employment grade and coronary heart disease in British civil servants. J Epidemiol Community Health (1978) 8.58
Myocardial ischaemia, risk factors and death from coronary heart-disease. Lancet (1977) 6.97
Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med (1977) 6.15
Magnitude and causes of socioeconomic differentials in mortality: further evidence from the Whitehall Study. J Epidemiol Community Health (1990) 5.93
Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-1979. Br Med J (Clin Res Ed) (1985) 5.48
Social class and coronary heart disease. Br Heart J (1981) 5.43
Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet (1980) 4.86
Cold weather and ischaemic heart disease. Br J Prev Soc Med (1966) 4.25
UK heart disease prevention project: incidence and mortality results. Lancet (1983) 4.19
A randomised controlled trial of anti-smoking advice: 10-year results. J Epidemiol Community Health (1982) 3.85
Mortality of employees of the Atomic Weapons Establishment, 1951-82. BMJ (1988) 3.82
Quantum annealing with manufactured spins. Nature (2011) 3.81
Incidence of cancers of the larynx and lung near incinerators of waste solvents and oils in Great Britain. Lancet (1992) 3.71
Plasma cholesterol concentration and mortality. The Whitehall Study. JAMA (1992) 3.37
Weight and mortality in the Whitehall Study. Br Med J (Clin Res Ed) (1982) 3.35
Plasma lipids and mortality: a source of error. Lancet (1980) 3.34
Current management of hypertension in hospital. Br Med J (1977) 3.31
Prevalence and prognosis of electrocardiographic findings in middle-aged men. Br Heart J (1978) 3.28
Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) (1983) 3.28
Alcohol and mortality: a U-shaped curve. Lancet (1981) 3.28
Heart disease prevention project: a randomised controlled trial in industry. Br Med J (1980) 3.03
What is epidemiology? Br Med J (1978) 2.96
Rearrangement of genetic information may produce immunoglobulin diversity. Nature (1979) 2.84
The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ (1990) 2.71
Blood-sugar and arterial disease. Lancet (1965) 2.70
INTERSALT study findings. Public health and medical care implications. Hypertension (1989) 2.69
How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J (Clin Res Ed) (1984) 2.64
Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J (1999) 2.61
Variability of angina. Some implications for epidemiology. Br J Prev Soc Med (1968) 2.58
Findings of the International Cooperative INTERSALT Study. Hypertension (1991) 2.53
Cigarette smoking by hospital patients. Br J Prev Soc Med (1971) 2.53
Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall study. Br Med J (Clin Res Ed) (1986) 2.52
Current management of hypertension in general practice. Br Med J (1977) 2.47
Alcohol and blood pressure: the INTERSALT study. BMJ (1994) 2.41
A cardiovascular survey of British postal workers. Lancet (1966) 2.25
Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation (1990) 2.15
The Small Area Health Statistics Unit: a national facility for investigating health around point sources of environmental pollution in the United Kingdom. J Epidemiol Community Health (1992) 2.15
Socioeconomic differentials in cancer among men. Int J Epidemiol (1991) 2.13
Hypertension. Br Med Bull (1971) 2.12
Blood pressure measurement in the United Kingdom Heart Disease Prevention Project. J Epidemiol Community Health (1978) 2.11
Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J (1970) 2.09
Sick individuals and sick populations. 1985. Bull World Health Organ (2001) 2.05
A randomised controlled trial of the effect on middle-aged men of advice to stop smoking. J Epidemiol Community Health (1978) 1.97
Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation (1994) 1.96
The specificity of autobiographical memory and imageability of the future. Mem Cognit (1996) 1.96
Quantitative assessment of exposure to dog (Can f 1) and cat (Fel d 1) allergens: relation to sensitization and asthma among children living in Los Alamos, New Mexico. J Allergy Clin Immunol (1995) 1.88
Cholesterol screening programmes: how much potential benefit? BMJ (1989) 1.87
A proposed trial of heart disease prevention in industry. Trans Soc Occup Med (1970) 1.75
Risk of stroke in non-rheumatic atrial fibrillation. Lancet (1987) 1.73
Wide-complex tachycardia: continued evaluation of diagnostic criteria. Acad Emerg Med (2000) 1.71
Predicting coronary heart disease from minor symptoms and electrocardiographic findings. Br J Prev Soc Med (1971) 1.70
Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. Circulation (2000) 1.69
Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections. Antimicrob Agents Chemother (2007) 1.68
Cigarettes, lung cancer, and coronary heart disease: the effects of inhalation and tar yield. J Epidemiol Community Health (1982) 1.68
Breathlessness, chronic bronchitis and reduced pulmonary function as predictors of cardiovascular disease mortality among men in England, Scotland and the United States. Int J Epidemiol (1989) 1.68
Epidemiology for the uninitiated. Screening. Br Med J (1978) 1.65
The contribution of intensive coronary care. Br J Prev Soc Med (1975) 1.65
Physical activity and coronary heart disease. Proc R Soc Med (1969) 1.63
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation (2000) 1.63
Blood pressure and associated factors in a rural Kenyan community. Hypertension (1985) 1.60
Epidemiology of acute asthma: IgE antibodies to common inhalant allergens as a risk factor for emergency room visits. J Allergy Clin Immunol (1989) 1.60
Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study. Br Med J (Clin Res Ed) (1985) 1.58
Incubation period of coronary heart disease. Br Med J (Clin Res Ed) (1982) 1.57
Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation (2001) 1.56
Population study of blood pressure and associated factors in St Lucia, West Indies. Int J Epidemiol (1982) 1.54
Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Hum Genet (2001) 1.50
Lung function and symptoms of cigarette smokers related to tar yield and number of cigarettes smoked. Lancet (1980) 1.50
Colon cancer and blood-cholesterol. Lancet (1974) 1.49
Prognosis in adult asthma: a national study. Br Med J (Clin Res Ed) (1987) 1.49
The purification and properties of microsomal palmitoyl-coenzyme A synthetase. Biochem J (1971) 1.48
How good is intercenter agreement in the identification of embolic signals in carotid artery disease? Stroke (1996) 1.47
Fetal monitoring in labor. J Natl Med Assoc (1976) 1.46
Conduct of surveys. Br Med J (1978) 1.45
Salt and blood pressure: a community trial. J Hum Hypertens (1989) 1.44
Implantation of a pulsatile external left ventricular assist device: role of intraoperative transesophageal echocardiography. J Cardiothorac Vasc Anesth (1994) 1.44
Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections. Antimicrob Agents Chemother (2007) 1.43
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapy. Ann Oncol (1999) 1.40
The structure and genetics of mouse immunoglobulins: an analysis of NZB myeloma proteins and sets of BALB/c myeloma proteins binding particular haptens. Cold Spring Harb Symp Quant Biol (1977) 1.38
Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam. Antimicrob Agents Chemother (2005) 1.38
A new treatment for endometriosis. Lancet (1989) 1.38
Restriction fragment length polymorphism of human mitochondrial DNA in a sample population from Apulia (southern Italy). Ann Hum Genet (1989) 1.37
Malocclusion prevalence in an ethnic Chinese population. Aust Dent J (1993) 1.34
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer. Ann Oncol (2012) 1.34
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study. J Antimicrob Chemother (2008) 1.29
The assessment of biological age: a report from the Department of Environment Study. Aging (Milano) (1994) 1.28
Relationship of binding of a calcium channel blocker to inhibition of contraction in intact cultured embryonic chick ventricular cells. Circ Res (1983) 1.27
Beta blockers after myocardial infarction: have trials changed practice? Br Med J (Clin Res Ed) (1984) 1.25
Gene/longevity association studies at four autosomal loci (REN, THO, PARP, SOD2). Eur J Hum Genet (1999) 1.25
Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension. Int J Epidemiol (1978) 1.25
In vivo measurement of water diffusion in the human heart. Magn Reson Med (1994) 1.23
Early mobilization and discharge after myocardial infarction. Mod Concepts Cardiovasc Dis (1972) 1.22
Characterization of a bidirectional promoter shared between two human genes related to aging: SIRT3 and PSMD13. Genomics (2006) 1.21
Age-related changes of the 3'APOB-VNTR genotype pool in ageing cohorts. Ann Hum Genet (1998) 1.18
Studies on medium-chain fatty acyl-coenzyme a synthetase. Enzyme fraction I: mechanism of reaction and allosteric properties. Biochem J (1968) 1.17